期刊文献+

5-氟尿嘧啶联合草酸铂时辰化疗治疗晚期大肠癌的临床观察 被引量:3

The Therapeutic Efficacy of Chronomodulated Chemotherapy with 5-Fluorouracil and Oxaliplatin in Late-stage Colorectal Carcinoma
下载PDF
导出
摘要 目的:观察5-氟尿嘧啶(5-Fu)和草酸铂联合时辰化疗治疗晚期大肠癌的临床疗效和毒性反应。方法:83例晚期大肠癌患者随机分为A组(时辰化疗组,41例)和B组(常规化疗组,42例)。所有患者行5-氟尿嘧啶(5-Fu,700mg/m2,d1-5)、亚叶酸钙(CF,130mg/m2,d1-5)加草酸铂(L-OHP,130mg/m2,d1)全身化疗,每21天为1个周期,共4到6个周期。A组时辰化疗时采用便携式微电脑输液泵定时给药:5-Fu和CF用药时间在22:00至次日10:00,其中75%的剂量在3:00至5:00滴入;L-OHP给药时间在10:00至22:00,其中75%剂量在3:00PM至5:00PM。B组用药时间安排在正常上班时间。结果:有效率(CR+PR)和临床获益率(CR+PR+NC)在A组分别为43.9%和82.9%,B组分别38.1%和78.5%,两组的有效率和临床获益率差别均无统计学意义(P>0.05);中位生存时间和无进展时间A组分别为18.5个月和7个月,B组分别为17.5个月和6个月;1年和2年生存率A组分别为75.6%和21.9%,B组分别为66.7%和21.4%;两组的总生存率无差别(P>... Objective:To evaluate the therapeutic efficacy and toxicity of chronomodulated chemotherapy regimen with 5-Fluorouracil and oxaliplatin for late-stage colorectal carcinoma.Methods: 83 patients with late-stage colorectal carcinoma were randomly divided into two groups to receive either chronomodulated chemotherapy ( group A, 41 cases) or routine chemotherapy ( group B, 42 cases). All of these patients were treated with intravenous 5-Fluorouracil (700 mg/m2, d1-5),folinic acid (130 mg/m2, d1-5) and oxaliplati...
出处 《肿瘤预防与治疗》 2009年第1期26-29,117,共5页 Journal of Cancer Control And Treatment
关键词 大肠癌 5氟尿嘧啶 草酸铂 时辰化疗 Colorectal Carcinoma 5-Fluorouracil Oxaliplatin Chronomodulated Chemotherapy
  • 相关文献

参考文献9

  • 1Clairambault J.Modeling oxaliplatin drug delivery to circadian rhythms in drug metabolism and host tolerance[].Advanced Drug Delivery Reviews.2007
  • 2Golfinopoulos V,Salanti G,Pavlidis N,et al.Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer:A meta-analysis[].The Lancet Oncology.2007
  • 3Simmonds PC.Palliative chemotherapy for advanced colorectal can-cer:systematic review and meta-analysis.Colorectal CancerCollaborative Group[].British Medical Journal.2000
  • 4Zori Comba A,Blajman C,Richardet E,et al.A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patients[].European Journal of Cancer.2001
  • 5Tournigand,C,Andre,T,Achille,E.FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study[].Journal of Clinical Oncology.2004
  • 6de Gramont A,Figer A,Seymour M,et al.Leucovorin and fluorouracil with or without oxaliplatin as first -line treatment in advanced colorectal cancer[].Journal of Clinical Oncology.2000
  • 7Smaaland R,Sothern RB,Laerum OD,et al.Rhythms in Human Bone Marrow and Blood Cells[].Chronobiology International.2002
  • 8Giacchetti,S,Bjarnason,G,Garufi,C,Genet,D,Iacobelli,S,Tampellini,M,Smaaland,R,Focan,C,Coudert,B,Humblet,Y,Canon,JL,Adenis,A,Lo Re,G,Carvalho,C,Schueller,J,Anciaux,N,Lentz,MA,Baron,B,Gorlia,T,Levi,F.Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: the European Organisation for Research and Treatment of Can[].Journal of Clinical Oncology.2006
  • 9Levi,F,Zidani,R,Misset,JL.Randomized multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer[].The Lancet.1997

同被引文献47

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部